ÎåÐÇÌåÓýÖ±²¥ to Report Fourth Quarter and Full Year 2020 Results on February 25
REDWOOD CITY, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- ÎåÐÇÌåÓýÖ±²¥ (Nasdaq:CDXS), a leading enzyme engineering company, today announced that it will report fourth quarter and full year 2020 financial results on Thursday, February 25, 2021, following the close of market. ÎåÐÇÌåÓýÖ±²¥ management will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the Company’s financial results and provide a business update.
Participants may access the live webcast on the , where it will be archived for 90 days. The live call can be accessed by dialing 877-705-2976 (domestic) or 201-689-8798 (international), conference IDÌý#13716352. A replay of the call will be available for 48 hours by dialing 877-660-6853 (domestic) or 201-612-7415 (international) conference ID #13716352.
About ÎåÐÇÌåÓýÖ±²¥
ÎåÐÇÌåÓýÖ±²¥ is a leading enzyme engineering company that applies its proprietary CodeEvolver® technology to develop products for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. ÎåÐÇÌåÓýÖ±²¥â€™ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes.
Forward-Looking Statements
To the extent that statements contained in this press release are not descriptions of historical facts regarding ÎåÐÇÌåÓýÖ±²¥, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties that could cause ÎåÐÇÌåÓýÖ±²¥â€™ future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. ÎåÐÇÌåÓýÖ±²¥ undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to ÎåÐÇÌåÓýÖ±²¥â€™ business in general, please refer to ÎåÐÇÌåÓýÖ±²¥â€™ prospectus supplement to be filed with the SEC, including the documents incorporated by reference therein, which include ÎåÐÇÌåÓýÖ±²¥â€™ Annual Report on Form 10-K filed with the SEC on February 28, 2020, ÎåÐÇÌåÓýÖ±²¥â€™ Quarterly Report on Form 10-Q filed with the SEC on November 6, 2020, and ÎåÐÇÌåÓýÖ±²¥â€™ other periodic reports filed with the SEC.
Investor Relations Contact:
Argot Partners
Stephanie Marks/Natallia Clancy
(212) 600-1902
Ìý
Source: ÎåÐÇÌåÓýÖ±²¥
Released February 11, 2021